Skip to main content
Fig. 10 | BMC Complementary Medicine and Therapies

Fig. 10

From: NMR and LCMS analytical platforms exhibited the nephroprotective effect of Clinacanthus nutans in cisplatin-induced nephrotoxicity in the in vitro condition

Fig. 10

The box and whisker plots of the relative quantities of the most significant metabolites in the corresponding media samples from the treated and untreated groups. Normal (mrc), cisplatin-induced (mrcis), aqueous pre-treatment (mraq), and pre-treatment with aqueous extract without any induction with cisplatin (mras) group. Intensity of metabolites (expressed as MEAN ± SEM) when comparing treatment groups and the cisplatin-induced group. ANOVA of significant value of T-test, p < 0.05, * and p < 0.01, **

Back to article page